SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022918
Filing Date
2020-05-07
Accepted
2020-05-07 16:31:28
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20200331.htm 10-Q 1663767
2 EX-31.1 cala-ex311_6.htm EX-31.1 15725
3 EX-32.1 cala-ex321_7.htm EX-32.1 7504
  Complete submission text file 0001564590-20-022918.txt   5522487

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cala-20200331.xml EX-101.INS 1199520
5 XBRL TAXONOMY EXTENSION SCHEMA cala-20200331.xsd EX-101.SCH 41024
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20200331_cal.xml EX-101.CAL 40774
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20200331_def.xml EX-101.DEF 97973
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20200331_lab.xml EX-101.LAB 312607
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20200331_pre.xml EX-101.PRE 233261
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 20856971
SIC: 2834 Pharmaceutical Preparations